Structure

Physi-Chem Properties

Molecular Weight:  261.1
Volume:  265.026
LogP:  0.646
LogD:  1.738
LogS:  -3.143
# Rotatable Bonds:  1
TPSA:  81.21
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.492
Synthetic Accessibility Score:  2.89
Fsp3:  0.0
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.076
MDCK Permeability:  6.232146915863268e-06
Pgp-inhibitor:  0.014
Pgp-substrate:  0.353
Human Intestinal Absorption (HIA):  0.069
20% Bioavailability (F20%):  0.913
30% Bioavailability (F30%):  0.672

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.663
Plasma Protein Binding (PPB):  93.55145263671875%
Volume Distribution (VD):  0.832
Pgp-substrate:  7.809872150421143%

ADMET: Metabolism

CYP1A2-inhibitor:  0.66
CYP1A2-substrate:  0.951
CYP2C19-inhibitor:  0.06
CYP2C19-substrate:  0.047
CYP2C9-inhibitor:  0.052
CYP2C9-substrate:  0.04
CYP2D6-inhibitor:  0.309
CYP2D6-substrate:  0.681
CYP3A4-inhibitor:  0.469
CYP3A4-substrate:  0.149

ADMET: Excretion

Clearance (CL):  5.792
Half-life (T1/2):  0.809

ADMET: Toxicity

hERG Blockers:  0.759
Human Hepatotoxicity (H-HT):  0.994
Drug-inuced Liver Injury (DILI):  0.963
AMES Toxicity:  0.774
Rat Oral Acute Toxicity:  0.99
Maximum Recommended Daily Dose:  0.917
Skin Sensitization:  0.747
Carcinogencity:  0.263
Eye Corrosion:  0.004
Eye Irritation:  0.401
Respiratory Toxicity:  0.986

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC122141

Natural Product ID:  NPC122141
Common Name*:   Annomontine
IUPAC Name:   4-(9H-pyrido[3,4-b]indol-1-yl)pyrimidin-2-amine
Synonyms:   Annomontine
Standard InCHIKey:  IUDMZJRPDRCJEB-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C15H11N5/c16-15-18-8-6-12(20-15)14-13-10(5-7-17-14)9-3-1-2-4-11(9)19-13/h1-8,19H,(H2,16,18,20)
SMILES:  N=c1[nH]ccc(n1)c1nccc2c1[nH]c1c2cccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL501413
PubChem CID:   5257090
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0001140] Harmala alkaloids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13370 Annona montana Species Annonaceae Eukaryota n.a. trunk bark n.a. DOI[10.1039/P19820001205]
NPO13370 Annona montana Species Annonaceae Eukaryota n.a. root n.a. DOI[10.1039/P19820001205]
NPO13370 Annona montana Species Annonaceae Eukaryota n.a. n.a. n.a. PMID[15568766]
NPO7436 Annona foetida Species Annonaceae Eukaryota n.a. n.a. n.a. PMID[16499336]
NPO30886 Annona foteida Species Annonaceae Eukaryota n.a. bark n.a. PMID[16499336]
NPO13370 Annona montana Species Annonaceae Eukaryota n.a. seed n.a. PMID[18687006]
NPO13370 Annona montana Species Annonaceae Eukaryota seeds n.a. n.a. PMID[18687006]
NPO13370 Annona montana Species Annonaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO13370 Annona montana Species Annonaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7436 Annona foetida Species Annonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13370 Annona montana Species Annonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1208 Organism Leishmania braziliensis Leishmania braziliensis IC50 = 34800.0 nM PMID[564239]
NPT3631 Organism Leishmania guyanensis Leishmania guyanensis IC50 > 613000.0 nM PMID[564239]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC122141 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.96 High Similarity NPC470204
0.9536 High Similarity NPC470203
0.9408 High Similarity NPC225018
0.9388 High Similarity NPC469811
0.9324 High Similarity NPC321911
0.932 High Similarity NPC143872
0.932 High Similarity NPC63545
0.9267 High Similarity NPC325903
0.9257 High Similarity NPC179787
0.9257 High Similarity NPC201380
0.8854 High Similarity NPC317105
0.8839 High Similarity NPC236711
0.878 High Similarity NPC307191
0.8776 High Similarity NPC125746
0.8742 High Similarity NPC204141
0.8725 High Similarity NPC115611
0.8707 High Similarity NPC96102
0.8649 High Similarity NPC105127
0.8649 High Similarity NPC84911
0.8581 High Similarity NPC29886
0.8581 High Similarity NPC261195
0.8562 High Similarity NPC17751
0.8562 High Similarity NPC274229
0.8562 High Similarity NPC280864
0.8562 High Similarity NPC288838
0.8533 High Similarity NPC110126
0.8533 High Similarity NPC73767
0.8477 Intermediate Similarity NPC469784
0.8477 Intermediate Similarity NPC469779
0.8477 Intermediate Similarity NPC279081
0.8477 Intermediate Similarity NPC469768
0.8477 Intermediate Similarity NPC469780
0.8477 Intermediate Similarity NPC469767
0.8477 Intermediate Similarity NPC469783
0.8477 Intermediate Similarity NPC469761
0.8456 Intermediate Similarity NPC325252
0.8435 Intermediate Similarity NPC82295
0.8424 Intermediate Similarity NPC280852
0.8421 Intermediate Similarity NPC469766
0.8405 Intermediate Similarity NPC97343
0.8397 Intermediate Similarity NPC53947
0.8389 Intermediate Similarity NPC198988
0.8387 Intermediate Similarity NPC470111
0.8385 Intermediate Similarity NPC478184
0.8366 Intermediate Similarity NPC190296
0.8355 Intermediate Similarity NPC230002
0.8355 Intermediate Similarity NPC284635
0.8354 Intermediate Similarity NPC82331
0.8354 Intermediate Similarity NPC476219
0.8344 Intermediate Similarity NPC470233
0.8343 Intermediate Similarity NPC108011
0.8313 Intermediate Similarity NPC474958
0.8313 Intermediate Similarity NPC293487
0.8289 Intermediate Similarity NPC88097
0.8261 Intermediate Similarity NPC44773
0.8261 Intermediate Similarity NPC215584
0.8258 Intermediate Similarity NPC159856
0.8258 Intermediate Similarity NPC314372
0.8253 Intermediate Similarity NPC471579
0.825 Intermediate Similarity NPC216643
0.8243 Intermediate Similarity NPC22079
0.8239 Intermediate Similarity NPC476297
0.8199 Intermediate Similarity NPC56765
0.8199 Intermediate Similarity NPC206819
0.8199 Intermediate Similarity NPC318065
0.8188 Intermediate Similarity NPC101165
0.816 Intermediate Similarity NPC478182
0.8153 Intermediate Similarity NPC471957
0.8144 Intermediate Similarity NPC280297
0.8098 Intermediate Similarity NPC478185
0.8092 Intermediate Similarity NPC218268
0.8086 Intermediate Similarity NPC135141
0.8086 Intermediate Similarity NPC475990
0.8086 Intermediate Similarity NPC92796
0.8063 Intermediate Similarity NPC232798
0.8061 Intermediate Similarity NPC478183
0.8061 Intermediate Similarity NPC49217
0.805 Intermediate Similarity NPC24678
0.805 Intermediate Similarity NPC105818
0.805 Intermediate Similarity NPC40070
0.8049 Intermediate Similarity NPC247987
0.8047 Intermediate Similarity NPC473380
0.8047 Intermediate Similarity NPC240088
0.8037 Intermediate Similarity NPC279918
0.8036 Intermediate Similarity NPC317054
0.8025 Intermediate Similarity NPC286427
0.8012 Intermediate Similarity NPC63751
0.8012 Intermediate Similarity NPC191415
0.8 Intermediate Similarity NPC216713
0.8 Intermediate Similarity NPC470823
0.7988 Intermediate Similarity NPC282231
0.7975 Intermediate Similarity NPC477591
0.7975 Intermediate Similarity NPC41257
0.7973 Intermediate Similarity NPC250361
0.7965 Intermediate Similarity NPC102755
0.7965 Intermediate Similarity NPC48938
0.7964 Intermediate Similarity NPC32534
0.7964 Intermediate Similarity NPC91895
0.795 Intermediate Similarity NPC141926
0.795 Intermediate Similarity NPC469786
0.795 Intermediate Similarity NPC73952
0.795 Intermediate Similarity NPC25008
0.795 Intermediate Similarity NPC469765
0.795 Intermediate Similarity NPC469763
0.795 Intermediate Similarity NPC259644
0.795 Intermediate Similarity NPC200214
0.795 Intermediate Similarity NPC469760
0.7941 Intermediate Similarity NPC59269
0.7939 Intermediate Similarity NPC90723
0.7922 Intermediate Similarity NPC314102
0.7922 Intermediate Similarity NPC251722
0.7919 Intermediate Similarity NPC284678
0.7911 Intermediate Similarity NPC470440
0.7901 Intermediate Similarity NPC80597
0.7901 Intermediate Similarity NPC212376
0.7901 Intermediate Similarity NPC75540
0.7901 Intermediate Similarity NPC34844
0.7901 Intermediate Similarity NPC70922
0.7901 Intermediate Similarity NPC211572
0.7898 Intermediate Similarity NPC231536
0.7895 Intermediate Similarity NPC265710
0.7891 Intermediate Similarity NPC46358
0.7885 Intermediate Similarity NPC59084
0.7885 Intermediate Similarity NPC2949
0.7874 Intermediate Similarity NPC99939
0.7874 Intermediate Similarity NPC15102
0.7874 Intermediate Similarity NPC308931
0.7867 Intermediate Similarity NPC473762
0.7866 Intermediate Similarity NPC221786
0.7866 Intermediate Similarity NPC474880
0.7857 Intermediate Similarity NPC194411
0.7853 Intermediate Similarity NPC469785
0.7849 Intermediate Similarity NPC16659
0.7844 Intermediate Similarity NPC56233
0.7844 Intermediate Similarity NPC49954
0.7844 Intermediate Similarity NPC474561
0.7844 Intermediate Similarity NPC54988
0.7834 Intermediate Similarity NPC473868
0.7834 Intermediate Similarity NPC63157
0.7829 Intermediate Similarity NPC62749
0.7818 Intermediate Similarity NPC229173
0.7815 Intermediate Similarity NPC473587
0.7809 Intermediate Similarity NPC324149
0.7805 Intermediate Similarity NPC469762
0.7785 Intermediate Similarity NPC20144
0.7778 Intermediate Similarity NPC473930
0.7765 Intermediate Similarity NPC477611
0.7765 Intermediate Similarity NPC326422
0.7763 Intermediate Similarity NPC475428
0.7756 Intermediate Similarity NPC169433
0.775 Intermediate Similarity NPC316069
0.7719 Intermediate Similarity NPC275305
0.7719 Intermediate Similarity NPC37423
0.7718 Intermediate Similarity NPC27740
0.7712 Intermediate Similarity NPC475450
0.7712 Intermediate Similarity NPC179365
0.7711 Intermediate Similarity NPC131718
0.7706 Intermediate Similarity NPC470498
0.7703 Intermediate Similarity NPC41174
0.7702 Intermediate Similarity NPC21605
0.7701 Intermediate Similarity NPC116555
0.7692 Intermediate Similarity NPC150259
0.7692 Intermediate Similarity NPC265576
0.7688 Intermediate Similarity NPC11126
0.7688 Intermediate Similarity NPC12649
0.7651 Intermediate Similarity NPC300238
0.7651 Intermediate Similarity NPC230869
0.7647 Intermediate Similarity NPC282398
0.7644 Intermediate Similarity NPC24864
0.764 Intermediate Similarity NPC478186
0.7633 Intermediate Similarity NPC160105
0.763 Intermediate Similarity NPC68354
0.7619 Intermediate Similarity NPC194640
0.7619 Intermediate Similarity NPC311276
0.7611 Intermediate Similarity NPC473342
0.7611 Intermediate Similarity NPC477166
0.7611 Intermediate Similarity NPC477167
0.7611 Intermediate Similarity NPC304187
0.7607 Intermediate Similarity NPC33421
0.7593 Intermediate Similarity NPC114209
0.7586 Intermediate Similarity NPC176199
0.7586 Intermediate Similarity NPC215795
0.7578 Intermediate Similarity NPC86288
0.756 Intermediate Similarity NPC253687
0.7551 Intermediate Similarity NPC91958
0.755 Intermediate Similarity NPC146373
0.755 Intermediate Similarity NPC166424
0.755 Intermediate Similarity NPC245244
0.7544 Intermediate Similarity NPC474897
0.7541 Intermediate Similarity NPC167710
0.7529 Intermediate Similarity NPC248454
0.7515 Intermediate Similarity NPC102423
0.7515 Intermediate Similarity NPC40779
0.7515 Intermediate Similarity NPC149265
0.7514 Intermediate Similarity NPC467063
0.7514 Intermediate Similarity NPC228835
0.7487 Intermediate Similarity NPC317701
0.7486 Intermediate Similarity NPC242209
0.7485 Intermediate Similarity NPC201700
0.7484 Intermediate Similarity NPC312092

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC122141 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8816 High Similarity NPD4374 Clinical (unspecified phase)
0.8792 High Similarity NPD1722 Approved
0.8707 High Similarity NPD198 Clinical (unspecified phase)
0.8533 High Similarity NPD786 Approved
0.8526 High Similarity NPD2837 Discontinued
0.8452 Intermediate Similarity NPD3100 Discontinued
0.8443 Intermediate Similarity NPD4649 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD1895 Discontinued
0.8364 Intermediate Similarity NPD4128 Approved
0.8263 Intermediate Similarity NPD4181 Approved
0.8242 Intermediate Similarity NPD1567 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD3341 Clinical (unspecified phase)
0.821 Intermediate Similarity NPD1853 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD3323 Discontinued
0.8129 Intermediate Similarity NPD4637 Clinical (unspecified phase)
0.8129 Intermediate Similarity NPD2007 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD2930 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD2875 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD6277 Clinical (unspecified phase)
0.805 Intermediate Similarity NPD2172 Phase 1
0.8039 Intermediate Similarity NPD1262 Discovery
0.8024 Intermediate Similarity NPD6827 Clinical (unspecified phase)
0.8024 Intermediate Similarity NPD6828 Phase 2
0.8012 Intermediate Similarity NPD977 Approved
0.8012 Intermediate Similarity NPD976 Approved
0.8012 Intermediate Similarity NPD975 Approved
0.8 Intermediate Similarity NPD715 Phase 3
0.7925 Intermediate Similarity NPD4547 Phase 3
0.7919 Intermediate Similarity NPD991 Phase 2
0.7919 Intermediate Similarity NPD992 Clinical (unspecified phase)
0.7904 Intermediate Similarity NPD2390 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD1313 Approved
0.7877 Intermediate Similarity NPD6278 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD1683 Approved
0.7848 Intermediate Similarity NPD1918 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD2478 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD1248 Discontinued
0.7829 Intermediate Similarity NPD3378 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD706 Phase 1
0.7824 Intermediate Similarity NPD5065 Approved
0.7811 Intermediate Similarity NPD3609 Approved
0.7811 Intermediate Similarity NPD3610 Approved
0.7805 Intermediate Similarity NPD1192 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD1707 Approved
0.7803 Intermediate Similarity NPD1708 Approved
0.7798 Intermediate Similarity NPD2640 Approved
0.7798 Intermediate Similarity NPD2333 Discontinued
0.7798 Intermediate Similarity NPD4779 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD2641 Approved
0.7797 Intermediate Similarity NPD5145 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD2006 Phase 2
0.7771 Intermediate Similarity NPD3943 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD2430 Phase 2
0.7759 Intermediate Similarity NPD1332 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD2927 Phase 3
0.7733 Intermediate Similarity NPD7111 Discontinued
0.7727 Intermediate Similarity NPD3385 Approved
0.7727 Intermediate Similarity NPD2793 Discontinued
0.7711 Intermediate Similarity NPD1403 Approved
0.7711 Intermediate Similarity NPD1404 Approved
0.7692 Intermediate Similarity NPD5069 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD5730 Phase 2
0.7688 Intermediate Similarity NPD40 Phase 2
0.7682 Intermediate Similarity NPD1598 Discontinued
0.768 Intermediate Similarity NPD2960 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD4075 Phase 2
0.7673 Intermediate Similarity NPD4047 Discontinued
0.767 Intermediate Similarity NPD6610 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD1015 Phase 2
0.7665 Intermediate Similarity NPD1016 Phase 2
0.7654 Intermediate Similarity NPD3419 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD5436 Phase 1
0.7647 Intermediate Similarity NPD3475 Approved
0.7647 Intermediate Similarity NPD3476 Approved
0.7644 Intermediate Similarity NPD6595 Phase 3
0.7644 Intermediate Similarity NPD5962 Phase 2
0.7637 Intermediate Similarity NPD2880 Discontinued
0.7636 Intermediate Similarity NPD2150 Discontinued
0.763 Intermediate Similarity NPD3505 Approved
0.763 Intermediate Similarity NPD3506 Approved
0.7625 Intermediate Similarity NPD5254 Discontinued
0.7622 Intermediate Similarity NPD1917 Discontinued
0.7597 Intermediate Similarity NPD803 Phase 1
0.7586 Intermediate Similarity NPD4079 Approved
0.7586 Intermediate Similarity NPD4076 Approved
0.7584 Intermediate Similarity NPD3486 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD3961 Discontinued
0.7574 Intermediate Similarity NPD1333 Phase 3
0.7569 Intermediate Similarity NPD3485 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD2119 Approved
0.7566 Intermediate Similarity NPD2118 Approved
0.7545 Intermediate Similarity NPD5418 Discontinued
0.7544 Intermediate Similarity NPD4184 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD2748 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD2639 Approved
0.7529 Intermediate Similarity NPD6203 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD2642 Approved
0.7528 Intermediate Similarity NPD4902 Discontinued
0.7514 Intermediate Similarity NPD4615 Phase 2
0.75 Intermediate Similarity NPD4023 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1029 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1030 Approved
0.75 Intermediate Similarity NPD1027 Approved
0.75 Intermediate Similarity NPD4462 Approved
0.75 Intermediate Similarity NPD4463 Approved
0.7486 Intermediate Similarity NPD2310 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD2316 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD1327 Discontinued
0.7485 Intermediate Similarity NPD1661 Suspended
0.7485 Intermediate Similarity NPD2185 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD4318 Clinical (unspecified phase)
0.7472 Intermediate Similarity NPD2868 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD2406 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD509 Phase 3
0.7458 Intermediate Similarity NPD5728 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD2385 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD8458 Clinical (unspecified phase)
0.7446 Intermediate Similarity NPD5462 Discontinued
0.7443 Intermediate Similarity NPD702 Clinical (unspecified phase)
0.7443 Intermediate Similarity NPD1873 Clinical (unspecified phase)
0.7433 Intermediate Similarity NPD3015 Discontinued
0.7432 Intermediate Similarity NPD7618 Phase 3
0.7432 Intermediate Similarity NPD7619 Phase 3
0.743 Intermediate Similarity NPD6217 Discontinued
0.743 Intermediate Similarity NPD4426 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD2580 Discontinued
0.7425 Intermediate Similarity NPD473 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD2442 Approved
0.7421 Intermediate Similarity NPD2443 Approved
0.7409 Intermediate Similarity NPD8488 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD2008 Discontinued
0.7405 Intermediate Similarity NPD1256 Approved
0.7405 Intermediate Similarity NPD1255 Approved
0.7405 Intermediate Similarity NPD1253 Approved
0.7405 Intermediate Similarity NPD6469 Phase 3
0.7405 Intermediate Similarity NPD1254 Approved
0.7405 Intermediate Similarity NPD6468 Clinical (unspecified phase)
0.7401 Intermediate Similarity NPD5806 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD9598 Discontinued
0.7389 Intermediate Similarity NPD5590 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD4030 Approved
0.7389 Intermediate Similarity NPD7394 Phase 2
0.7389 Intermediate Similarity NPD4029 Approved
0.7389 Intermediate Similarity NPD4028 Approved
0.7389 Intermediate Similarity NPD3942 Approved
0.7389 Intermediate Similarity NPD3944 Approved
0.7386 Intermediate Similarity NPD9583 Approved
0.7381 Intermediate Similarity NPD2865 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD768 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD4298 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD809 Discontinued
0.7368 Intermediate Similarity NPD5744 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD2165 Phase 1
0.7358 Intermediate Similarity NPD45 Approved
0.7358 Intermediate Similarity NPD6554 Approved
0.7356 Intermediate Similarity NPD966 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD3654 Approved
0.7355 Intermediate Similarity NPD947 Approved
0.7351 Intermediate Similarity NPD6664 Approved
0.7351 Intermediate Similarity NPD3830 Phase 1
0.7333 Intermediate Similarity NPD6721 Phase 1
0.733 Intermediate Similarity NPD1272 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD3114 Approved
0.7321 Intermediate Similarity NPD3113 Approved
0.7321 Intermediate Similarity NPD3115 Approved
0.7321 Intermediate Similarity NPD3112 Approved
0.7318 Intermediate Similarity NPD5892 Approved
0.7317 Intermediate Similarity NPD1528 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD482 Approved
0.7305 Intermediate Similarity NPD1303 Phase 1
0.7305 Intermediate Similarity NPD695 Discontinued
0.7302 Intermediate Similarity NPD2364 Suspended
0.7296 Intermediate Similarity NPD490 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD8431 Approved
0.7285 Intermediate Similarity NPD268 Approved
0.7285 Intermediate Similarity NPD271 Approved
0.7285 Intermediate Similarity NPD270 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD1227 Phase 2
0.7277 Intermediate Similarity NPD8410 Clinical (unspecified phase)
0.7277 Intermediate Similarity NPD8493 Clinical (unspecified phase)
0.7277 Intermediate Similarity NPD1506 Discontinued
0.7273 Intermediate Similarity NPD3348 Phase 2
0.7273 Intermediate Similarity NPD749 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD2751 Phase 1
0.7268 Intermediate Similarity NPD2411 Approved
0.7268 Intermediate Similarity NPD6180 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD5106 Approved
0.7263 Intermediate Similarity NPD5105 Approved
0.7255 Intermediate Similarity NPD9357 Approved
0.7253 Intermediate Similarity NPD8110 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD5315 Discontinued
0.7248 Intermediate Similarity NPD9392 Approved
0.7248 Intermediate Similarity NPD9396 Approved
0.7246 Intermediate Similarity NPD1257 Approved
0.7244 Intermediate Similarity NPD9305 Clinical (unspecified phase)
0.7243 Intermediate Similarity NPD4294 Phase 2
0.7241 Intermediate Similarity NPD4024 Phase 3
0.7238 Intermediate Similarity NPD7026 Phase 2
0.7234 Intermediate Similarity NPD6816 Phase 3
0.7232 Intermediate Similarity NPD2144 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data